MTM Investment Management »

Humacyte shares owned by MTM Investment Management

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by MTM Investment Management from 13F filings

Historical chart of MTM Investment Management investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by MTM Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by MTM Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1k 1.1k 0.96

More positions owned by MTM Investment Management

Apple (AAPL)
Lowe's Companies (LOW)
T Rowe Price Etf Inc Capital Appreciation Equity Cap Appreciation (TCAF)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Microsoft Corporation (MSFT)
Amplify Cwp Enhanced Dividend Income Etf Cwp Enhanced Div (DIVO)
McKesson Corporation (MCK)
Kinder Morgan (KMI)
Broadcom (AVGO)
Ishares Tr Rus 1000 Grw Etf Rus 1000 Grw Etf (IWF)
Spdr S&p 500 Etf Tr Unit (SPY)
Chevron Corporation (CVX)
Commerce Bancshares (CBSH)
First Trust Small Cap Core Alphadex Fund Com Shs (FYX)

View all positions for MTM Investment Management

Top funds holding Humacyte

BlackRock
Vanguard Group
Geode Capital Management
UBS Group
State Street Corporation
Woodline Partners
Susquehanna International
Two Sigma Investments
Charles Schwab Investment Management
Northern Trust
Millennium Management
Citadel Advisors
Bnp Paribas Arbitrage, Snc
LPL Financial
Barclays

View all funds holding Humacyte